Estrella Immunopharma, Inc. (ESLA) Net Cash Provided by (Used in) Investing Activities USD 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Estrella Immunopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate for 2023.
  • Estrella Immunopharma, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending September 30, 2023 was -$112 K.
  • Estrella Immunopharma, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $36.2 M.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$112 K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q1 2023 $77.8 K Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.